Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple MyelomaYukiko Cho, Yasushi Okoshi, Fumie Fujisawa et al.|Acta Haematologica|2015Cited by 1
Predicting bortezomib-related severe neurologic adverse events by measuring proteasome activity in PBMCs.Yukiko Cho, Mitsuo Hori, Yasushi Okoshi et al.|Journal of Clinical Oncology|2012Cited by 0